Solving the Last Mile Problem
From FDA Approval to Real-World Adoption
Your patient access programs handle insurance, copay, and navigators. But the real barrier to adoption is practice-level operational readiness. We solve that — so every eligible patient can get on therapy.
Millions Eligible. Thousands Treated.
The Barrier Isn't What You Think.
50+ Discrete Steps per Patient
Genetic testing, baseline imaging, prior authorization, biweekly infusions, surveillance imaging at specific intervals, dose calculations, adverse event monitoring, registry reporting — coordinated across 8+ external parties over 12-24 months.
Managed by Spreadsheets & Sticky Notes
Coordinators spend 6+ hours per day on manual tracking. Faxes fail. Authorizations expire. Imaging gets missed. One mistake in a 50-step protocol can derail an entire treatment course.
Practices Simply Don't Prescribe
Community practices that can't efficiently manage these protocols choose not to offer the therapy. Every practice that opts out is a prescribing channel permanently closed — and lost patient lifetime value.
Same Practice. Same Patients.
Completely Different Reality.
This is 4 patients. Now imagine 50. That's one coordinator's caseload.
Zero missed safety imaging · 100% dose accuracy · 2-3x more patients per coordinator
We Don't Compete With Your Programs — We Complete Them
Patient access programs solve the access problem. MemberCare solves the operations problem. Both are required for real-world adoption.
The Economics Are Overwhelming
Every practice you enable is a prescribing channel opened. Every patient kept on therapy is lifetime value captured.
Commercial Impact
- More prescribers — practices "not ready" become willing
- Faster starts — reduce Rx-to-first-infusion time
- Better retention — patients stay on therapy longer
Medical & Safety
- Safer administration — built-in safety protocols
- Registry compliance — structured data for CMS
- Fewer adverse events from missed checkpoints
Market Position
- First mover — practices standardize on one system
- Lock-in — switching protocols carries clinical risk
- Real-world evidence for label expansion & payer negotiation
The First Drug to Make Adoption Easy Wins the Installed Base
When competing therapies target the same patient population, the manufacturer that invests in practice enablement captures the prescribing relationship first. Once a site is operationally configured for one therapy, switching carries real clinical risk. This is not a technology decision. It is a market position decision.
One Protocol Engine. Any Practice Size.
The same platform calibrates its delivery to each site's maturity — from solo practices to academic medical centers. Same safety guarantees, adapted experience.
Guided Mode
Solo or small practice starting a complex therapy for the first time
- Step-by-step workflow wizards
- Mandatory pre-infusion checklists
- AI nurse assistant with proactive alerts
- Strict safety blocking, no overrides
Co-Pilot Mode
Regional infusion center or multi-physician group expanding therapy offerings
- Streamlined confirmations
- AI as co-pilot, not driver
- Configurable checklists with smart defaults
- Exception-based alerting
Autopilot Mode
Academic medical center or high-volume specialty pharmacy
- Power-user batch operations
- AI for documentation & analytics
- Population-level dashboards
- Exception-only notifications
Same foundation across all tiers: Same protocol templates · Same blocking rules · Same safety guarantees · Zero custom code
One Platform. Any Protocol. Any Therapy.
Describe your protocol in plain English. Our AI builds the workflow. Deploy new therapy protocols as fast as you can describe them.
Every therapy in your portfolio. Deploy new protocols in hours, not months.
Partnership Models Designed for Pharma
Every model accelerates real-world adoption. Choose the engagement that fits your launch stage.
Practice Enablement
Fund MemberCare deployment at prescribing sites. Remove operational barriers at the point of care. Get practices prescribing your therapy within weeks.
Real-World Evidence
Structured RWE from every patient interaction. Outcomes, adverse events, adherence — data for label expansions, payer negotiations, and post-market surveillance.
Co-Development
Co-create AI agents and protocols for new launches. Drug-specific AI support ready on launch day — not 12 months later.
Digital Companion
Branded patient-facing AI agent for your therapy. Education, side effect management, adherence support, and 24/7 symptom guidance in 100+ languages.
Start With a Pilot
10 practices. 90 days. Drug-specific configuration. Measure the impact before scaling nationally.
Integration & Configuration
Drug-specific protocol setup. AI agent deployment. Custom branding and templates. Testing with 3-5 pilot clinics. Staff training and support.
Live Operations & Scale
Full network deployment. Patients enrolled and managed on protocol. RWE data collection. Revenue tracking activation. Real-time MemberCare support.
Results & National Rollout
Impact analysis: prescribing volume, protocol compliance, patient retention. Optimize pricing and adoption. Expand across your entire prescriber network.
Your Breakthrough Therapies Deserve
Widespread Adoption
The last mile between FDA approval and real-world adoption is the hardest. MemberCare closes that gap — so every eligible patient can get on therapy.
Or call us: 214.226.5319